โ† All deals

nPhase, Inc.

Other Technologyclinical researchAI platformSeries D
๐Ÿ“ Atlantic Beach, FL, USA
StreetZero Signal 68
Be the first to signal interest

About nPhase, Inc.

nPhase, Inc. is a clinical research technology company that commercializes Vanderbilt-developed REDCap technology. It offers an AI-native clinical data platform that connects clinical trial and real-world data for pharmaceutical sponsors and life sciences organizations. The flagship nPhase.ai platform integrates data from sites, labs, patients, and sensors while providing AI agents for discrepancy flagging and statistical programming support. Headquartered in Atlantic Beach, Florida, the company focuses on modernizing clinical data management and workflows.

LATEST FUNDINGSeries D
$15.0M
Announced 2026-11-18
TOTAL RAISED$30M
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for nPhase, Inc..

Free plan includes 3 full deal profiles every month.

Key highlights

  • Raised $30M Series D led by Viking Global Investors in November 2026.
  • First equity financing since 2017 to expand AI-native clinical data platform.
  • Commercializes Vanderbilt REDCap technology for sponsors and academic researchers.
  • Platform integrates trial, real-world, and sensor data with agentic AI tools.
  • Headquartered in Atlantic Beach, Florida.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account